{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7208,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "go_to_market",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/14",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "go_to_market",
      "function": "plan_implementation",
      "notes": "The superscript 3 in '2000^3' appears to be a typo or formatting error in the source slide.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/15",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide contrasts a large incumbent's metrics with the company's own USP.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/16",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 16,
          "beatId": "c803871c-1fe4-460a-b52a-5d0b781b1cd3",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Competition",
          "beatSlug": "sequoia-pitch-competition",
          "evidence": "The deck analyzes the competitive landscape",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The slide outlines CE marking in Europe and the ongoing FDA PMA review process, including specific audit and inspection history.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/17",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "other",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/18",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a numbered list format to present future product roadmap items.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/19",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/20",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/21",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d9bf-754b-bf82-9848326f26f9",
      "docSlug": "30930ac7a1e94d1cb6884cc2337d8609",
      "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
      "authorId": "nemaura-medical",
      "authorName": "Nemaura Medical",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d9bf-754b-bf82-9848326f26f9/22",
      "deckHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9",
      "deckAnchorHref": "/decks/019de075-d9bf-754b-bf82-9848326f26f9#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/H6ggnSEqBkSetbYME-uUyuVBUJOvjw8Up8lSBxF2H6U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzY3YjQwMThkOWJiMmQxZTAxZWE0NDFmNjg1NzUzZC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/1",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "3bd59596-460d-4a33-994d-5327f8bc4717",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, mission, executive summary, and team bio slides provide an introduction to the company and its goals.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/UX4qdp_0jvQ5h21xqLFeG6Tp0GkPeyPQnJnYs0ax-n4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzY3YjQwMThkOWJiMmQxZTAxZWE0NDFmNjg1NzUzZC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/YBTpA45G5bBFtM15vhbNGOOfhqwwlN3L8kwoDVn2dOQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzY3YjQwMThkOWJiMmQxZTAxZWE0NDFmNjg1NzUzZC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/lAhVcXAAmZXELWWl4K7EPpdUjYtYj2CO5MaKsbAvDU4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzY3YjQwMThkOWJiMmQxZTAxZWE0NDFmNjg1NzUzZC9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/2",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "3bd59596-460d-4a33-994d-5327f8bc4717",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, mission, executive summary, and team bio slides provide an introduction to the company and its goals.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 3,
      "slideType": "appendix_data",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/3",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "3bd59596-460d-4a33-994d-5327f8bc4717",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, mission, executive summary, and team bio slides provide an introduction to the company and its goals.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 4,
      "slideType": "mission",
      "function": "inspire_vision",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/4",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "3bd59596-460d-4a33-994d-5327f8bc4717",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, mission, executive summary, and team bio slides provide an introduction to the company and its goals.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 5,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/5",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "3bd59596-460d-4a33-994d-5327f8bc4717",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The cover, mission, executive summary, and team bio slides provide an introduction to the company and its goals.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 6,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide is split into two sections: Leadership (with headshots and bios) and Blue Chip Investors (with logos).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/6",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 7,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style chart to visualize clinical trial progress for seven distinct programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/7",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a detailed biological mechanism diagram showing the interaction of KOR, dynorphin, and neurotransmitters.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/8",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 8,
          "beatId": "6e6023e0-0615-40b5-b8c5-2313f80d541d",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Solution",
          "beatSlug": null,
          "evidence": "Slides presenting Navacaprant as a potential first novel mechanism approved in MDD in decades.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 9,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The slide uses a comparative structure to justify the strategic shift in trial design post-acquisition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/9",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-9",
      "loopMatches": [
        {
          "to": 10,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "2bd7ba03-4d81-4e19-bd9c-4d10d02b1402",
          "evidence": "The complication slides highlighting current treatment limitations.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet needs in brain disease treatment?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 9,
          "beatId": "ae418749-a82f-4297-ba0f-ee67621e0c10",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Complication",
          "beatSlug": "complication",
          "evidence": "Slides highlighting the limitations of current treatments and the unmet needs in brain disease treatment.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 10,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Graphs depict prespecified statistical sensitivity analysis for moderate-to-severe patients (n=100; baseline HAMD-17 >= 22).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/10",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-10",
      "loopMatches": [
        {
          "to": 10,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "2bd7ba03-4d81-4e19-bd9c-4d10d02b1402",
          "evidence": "The complication slides highlighting current treatment limitations.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet needs in brain disease treatment?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 12,
          "from": 10,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "79f06519-3b69-4341-b391-de3522d321e9",
          "evidence": "The traction slides showcasing Navacaprant's efficacy and safety data.",
          "position": 1,
          "objective": "How can Navacaprant address the unmet needs in depression and anhedonia treatment?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 9,
          "beatId": "ae418749-a82f-4297-ba0f-ee67621e0c10",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Complication",
          "beatSlug": "complication",
          "evidence": "Slides highlighting the limitations of current treatments and the unmet needs in brain disease treatment.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        },
        {
          "to": 12,
          "from": 10,
          "beatId": "d8d5c84b-60b8-4c4d-81e2-30e06c864ec8",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Evidence",
          "beatSlug": "evidence",
          "evidence": "Slides showcasing Navacaprant's efficacy and safety data.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The table displays statistical significance (p-values) for multiple clinical endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/11",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-11",
      "loopMatches": [
        {
          "to": 12,
          "from": 10,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "79f06519-3b69-4341-b391-de3522d321e9",
          "evidence": "The traction slides showcasing Navacaprant's efficacy and safety data.",
          "position": 1,
          "objective": "How can Navacaprant address the unmet needs in depression and anhedonia treatment?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "d8d5c84b-60b8-4c4d-81e2-30e06c864ec8",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Evidence",
          "beatSlug": "evidence",
          "evidence": "Slides showcasing Navacaprant's efficacy and safety data.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "TEAE = Treatment-Emergent Adverse Events. Data compares Navacaprant vs Placebo (n=102 each).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/12",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-12",
      "loopMatches": [
        {
          "to": 12,
          "from": 10,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "79f06519-3b69-4341-b391-de3522d321e9",
          "evidence": "The traction slides showcasing Navacaprant's efficacy and safety data.",
          "position": 1,
          "objective": "How can Navacaprant address the unmet needs in depression and anhedonia treatment?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "d8d5c84b-60b8-4c4d-81e2-30e06c864ec8",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Evidence",
          "beatSlug": "evidence",
          "evidence": "Slides showcasing Navacaprant's efficacy and safety data.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 13,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "Includes a timeline diagram for the randomized, double-blind treatment phase and a summary table of inclusion criteria and endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/13",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 14,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table uses a color-coded legend for 'Degree of preference' (High, Medium, Low).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/14",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 15,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "Includes qualitative expert testimonials regarding pricing and market access.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/15",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 15,
          "beatId": "71a39db9-74d4-4c7b-8ac8-ff73acc17ac3",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "A slide estimating the large MDD patient population and potential upside for Navacaprant.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 16,
      "slideType": "why_now",
      "function": "plan_implementation",
      "notes": "The diagram illustrates a decision-tree process based on clinical trial outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/16",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 17,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a biological pathway diagram showing V1aR antagonism and downstream signaling effects.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/17",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a 'Signal Seeking' framework to justify clinical development decisions based on effect size.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/18",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 19,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/19",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 20,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table compares key metrics like EC50, half-life, brain:plasma ratio, selectivity, bioavailability, and molecular weight.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/20",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
      "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
      "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
      "authorId": "neumora-therapeutics",
      "authorName": "Neumora Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7794254,
      "pageNumber": 21,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological pathway diagram to illustrate the mechanism of action (PAM) and the pathology of schizophrenia.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/21",
      "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
      "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}